Unlock stock picks and a broker-level newsfeed that powers Wall Street.
ASX - Delayed Quote AUD

4DMedical Limited (4DX.AX)

Compare
0.2450
-0.0100
(-3.92%)
As of 10:21:01 AM GMT+11. Market Open.
Loading Chart for 4DX.AX
  • Previous Close 0.2550
  • Open 0.2500
  • Bid 0.2450 x --
  • Ask 0.2500 x --
  • Day's Range 0.2450 - 0.2500
  • 52 Week Range 0.2450 - 0.7150
  • Volume 318,216
  • Avg. Volume 1,057,086
  • Market Cap (intraday) 121.172M
  • Beta (5Y Monthly) 1.36
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1100
  • Earnings Date Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.78

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations. The company was incorporated in 2012 and is based in Carlton, Australia.

4dmedical.com

145

Full Time Employees

June 30

Fiscal Year Ends

Recent News: 4DX.AX

View More

Performance Overview: 4DX.AX

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

4DX.AX
48.96%
S&P/ASX 200 [XJO] (^AXJO)
5.25%

1-Year Return

4DX.AX
62.31%
S&P/ASX 200 [XJO] (^AXJO)
1.11%

3-Year Return

4DX.AX
70.48%
S&P/ASX 200 [XJO] (^AXJO)
3.16%

5-Year Return

4DX.AX
83.33%
S&P/ASX 200 [XJO] (^AXJO)
52.55%

Compare To: 4DX.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4DX.AX

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    114.86M

  • Enterprise Value

    103.73M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    17.22

  • Price/Book (mrq)

    1.92

  • Enterprise Value/Revenue

    20.13

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -23.32%

  • Return on Equity (ttm)

    -52.37%

  • Revenue (ttm)

    5.86M

  • Net Income Avi to Common (ttm)

    -39.54M

  • Diluted EPS (ttm)

    -0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.95M

  • Total Debt/Equity (mrq)

    8.05%

  • Levered Free Cash Flow (ttm)

    -28.41M

Research Analysis: 4DX.AX

View More

Company Insights: 4DX.AX

Research Reports: 4DX.AX

View More

People Also Watch